ElevateBio
PrivateLast Round
Series D
May 24, 2023
Total Funding Raised
$1.25B
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ElevateBio is a biotechnology company that provides an integrated platform for the discovery, development, and manufacturing of cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ElevateBio Comparables
Compare ElevateBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RoslinCT | 85% | |
| Resilience | 83% | |
| GeneFab | 81% | |
ElevateBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 24, 2023 | ||||
| Series C | Mar 15, 2021 | ||||
| Series B | Mar 30, 2020 | ||||
| Series A | May 13, 2019 |
Key People
Founding team and executive leadership
ElevateBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series B, Series A, Series D, Series C |
| Redmile Group | Series B, Series A, Series D, Series C |
| MPM Capital | Series B, Series D, Series C, Series A |
| SoftBank Investment Advisers | Series D, Series C |
| Fidelity Management & Research Company | Series D, Series C |
| MPM BioImpact | Series A, Series B, Series D, Series C |
| SoftBank Group | Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 5, 2026
Christopher Murphy named Chief Executive Officer and Board member.
- Jan 5, 2026
Chris appointed as the new Executive Chairman.
ElevateBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ElevateBio's valuation, stock price, and market status.